Reliance Industries : Investment in Vitalic Health Private Limited and its subsidiaries

August 18, 2020
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Plot No. C/1,
Dalal Street,	G Block, Bandra - Kurla Complex,
Mumbai 400 001	Bandra (East), Mumbai 400 051
Scrip Code: 500325 / 890147	Trading Symbol: RELIANCE / RELIANCEPP

Dear Sirs,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Investment in Vitalic Health Private Limited and its subsidiaries

Reliance Retail Ventures Limited ("RRVL"), a subsidiary of Reliance Industries Limited ("RIL" or the "Company") has acquired equity shares of Vitalic Health Pvt. Ltd. ("Vitalic") and its subsidiaries for a cash consideration of ~INR 620 crores (Indian Rupees six hundred twenty crores only). The said investment represents ~60% holding in the equity share capital of Vitalic and direct 100% equity ownership of its subsidiaries, viz: Tresara Health Private Limited ("THPL"), Netmeds Marketplace Limited ("NML") and Dadha Pharma Distribution Pvt Limited ("DPDPL").

RRVL will further acquire equity stake in Vitalic, through a mix of secondary purchase and primary investment, for at least 80% stake by April 2024, with an option to increase to 100% ownership.

Vitalic was incorporated in India on September 7, 2015. Vitalic and its subsidiaries are in the business of pharma distribution and sales, and business support services. Its subsidiary also runs an online pharmacy platform - Netmeds - to connect customers to pharmacists and enable doorstep delivery of medicines, nutritional health and wellness products.

Vitalic is an early stage company, with a consolidated turnover of INR 221.02 crore, INR

304.74 crore and INR 184.23 crore, and Net Profit (Loss) of INR (184.35) crore, INR (192.95) crore and INR (74.69) crore in FY 2020, FY 2019 and FY 2018 respectively.

Regd. Office: 3rd Floor, Maker Chambers IV, 222, Nariman Point, Mumbai- 400 021, India

Phone #: [phone], Telefax: [phone]. E-mail:[e-mail], Website: www.ril.com

CIN- L17110MH1973PLC019786

DPDPL, incorporated on September 15, 2015, had a turnover of INR 132.52 crore, INR

149.05 crore and INR 114.52 crore, and Net Profit (Loss) of INR 0.46 crore, INR 1.21 crore and INR 1.10 crore in FY 2020, FY 2019 and FY 2018 respectively.

THPL, incorporated on August 21, 2015, had a turnover of INR 85.80 crore, INR 191.50 crore and INR 78.52 crore, and Net Profit (Loss) of INR (14.87) crore, INR (10.93) crore and INR (8.82) crore in FY 2020, FY 2019 and FY 2018 respectively.

NML, incorporated on August 24, 2010, had a turnover of INR 7.77 crore, INR 13.94 crore and INR 10.05 crore, and Net Profit (Loss) of INR (164.15) crore, INR (174.41) crore and INR (59.56) crore in FY 2020, FY 2019 and FY 2018 respectively.

The aforesaid investment will further enhance affordable availability of essential quality health care products & services by the group, while furthering group's digital commerce initiatives, with user access across all daily essential needs.

No governmental or regulatory approvals were required for the said investment. The investment does not fall within related party transactions and none of RIL's promoter / promoter group / group companies have any interest in the transaction.

Thanking you,

Yours faithfully,

For Reliance Industries Limited

Savithri Parekh

Joint Company Secretary & Compliance Officer

Copy to:
The Luxembourg Stock Exchange	Singapore Stock Exchange
Societe de la Bourse de Luxembourg	2 Shenton Way,
35A boulevard Joseph II	#19- 00 SGX Centre 1,
B P 165, L-2011 Luxembourg	Singapore 068804

Regd. Office: 3rd Floor, Maker Chambers IV, 222, Nariman Point, Mumbai- 400 021, India

Phone #: [phone], Telefax: [phone]. E-mail:[e-mail], Website: www.ril.com

CIN- L17110MH1973PLC019786